Children’s Hospital Los Angeles has expanded its cell and gene therapy program to include 12 FDA-approved therapies.
The program now offers more cell and gene therapies than any pediatric center on the West Coast, according to a March 5 news release from the hospital.
The therapies treat neuromuscular disorders, blood disorders, cancer, inherited retinal disease, dermatologic and transplantation-associated conditions.
The hospital plans to launch a clinical trial to study a sickle cell gene therapy product, as well as a CAR T-cell therapy developed by investigators at Children’s Hospital Los Angeles for pediatric solid tumors, the release said.
The post Children’s Hospital Los Angeles expands cell therapy program appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Source: Read Original Article
